Regeneron Pharmaceuticals (REGN) Stock Forecast for 2023 – 2026. Sell or Buy Prediction

Regeneron Pharmaceuticals (REGN) Stock Forecast for 2023 – 2026. Sell or Buy?

Updated: December 6, 2023 (05:51)

Sector: Healthcare

The share price of Regeneron Pharmaceuticals, Inc. (REGN) now

Latest session on the 5th of December for
Regeneron Pharmaceuticals, Inc. is negative
Trading Volume: 312837
Open: 817.81 /  High: 823.68 /  Low: 809.243
What analysts predict: $920.09
52-week High/Low: $853.97 / $668

50/200 Day Moving Average: $813.12 / $784.41

This figure corresponds to the Average Price over the previous 50/200 days. For Regeneron Pharmaceuticals stocks, the 50-day moving average is the support level today.

For Regeneron Pharmaceuticals stocks, the 200-day moving average is the support level today.

Are you interested in Regeneron Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Regeneron Pharmaceuticals stock price in 2024, 2025, 2026, 2027, 2028. How much will one Regeneron Pharmaceuticals share be worth in 2024 - 2028?

When should I take profit in Regeneron Pharmaceuticals stock? When should I record a loss on Regeneron Pharmaceuticals stock? What are analysts' forecasts for Regeneron Pharmaceuticals stock? What is the future of Regeneron Pharmaceuticals stock? We forecast Regeneron Pharmaceuticals stock performance using neural networks based on historical data on Regeneron Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Regeneron Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Regeneron Pharmaceuticals shares. This happens once a day.




Historical and forecast chart of Regeneron Pharmaceuticals stock

The chart below shows the historical price of Regeneron Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Regeneron Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Regeneron Pharmaceuticals, Inc. is an American biotech company headquartered in Eastview, near Tarrytown, New York. The company was founded in 1988. Initially, it focused on neurotrophic factors and their regenerative capabilities (hence the name), and then branched out into the study of both cytokine and tyrosine kinase receptors.

Regeneron Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Dec 08 835.68 823.11 842.90 2.40
Dec 09 837.01 822.01 856.83 4.24
Dec 10 846.66 826.61 868.33 5.05
Dec 11 841.78 833.16 852.82 2.36
Dec 12 848.24 835.22 867.52 3.87
Dec 13 842.54 824.21 850.90 3.24
Dec 14 837.96 829.11 846.27 2.07
Dec 15 828.58 818.77 833.88 1.85
Dec 16 829.64 823.26 848.22 3.03
Dec 17 803.09 795.89 808.48 1.58
Dec 18 805.91 798.95 821.90 2.87
Dec 19 815.97 802.66 821.72 2.37
Dec 20 821.98 803.04 832.76 3.70
Dec 21 811.72 795.36 819.25 3.00
Dec 22 805.49 799.56 823.27 2.97
Dec 23 801.10 785.98 807.00 2.67
Dec 24 818.54 808.06 827.70 2.43
Dec 25 824.30 809.79 838.54 3.55
Dec 26 832.74 815.15 851.66 4.48
Dec 27 842.33 832.63 854.46 2.62
Dec 28 846.65 836.08 866.42 3.63
Dec 29 848.27 826.83 854.24 3.32
Dec 30 875.14 858.62 893.07 4.01
Dec 31 861.14 846.81 878.78 3.77
Jan 01 853.70 840.86 865.99 2.99
Jan 02 878.01 865.65 883.92 2.11
Jan 03 863.69 849.87 877.50 3.25
Jan 04 848.76 836.27 854.74 2.21
Jan 05 853.11 833.18 867.85 4.16
Jan 06 864.30 842.17 877.02 4.14

Regeneron Pharmaceuticals Daily Price Targets


Regeneron Pharmaceuticals Stock Forecast 12-08-2023.

Forecast target price for 12-08-2023: $835.68.
Positive dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 2.348%.
Pessimistic target level: 823.11
Optimistic target level: 842.90

Regeneron Pharmaceuticals Stock Forecast 12-09-2023.

Forecast target price for 12-09-2023: $837.01.
Positive dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 4.064%.
Pessimistic target level: 822.01
Optimistic target level: 856.83

Regeneron Pharmaceuticals Stock Forecast 12-10-2023.

Forecast target price for 12-10-2023: $846.66.
Positive dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 4.805%.
Pessimistic target level: 826.61
Optimistic target level: 868.33

Regeneron Pharmaceuticals Stock Forecast 12-11-2023.

Forecast target price for 12-11-2023: $841.78.
Negative dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 2.306%.
Pessimistic target level: 833.16
Optimistic target level: 852.82

Regeneron Pharmaceuticals Stock Forecast 12-12-2023.

Forecast target price for 12-12-2023: $848.24.
Positive dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 3.723%.
Pessimistic target level: 835.22
Optimistic target level: 867.52

Regeneron Pharmaceuticals Stock Forecast 12-13-2023.

Forecast target price for 12-13-2023: $842.54.
Negative dynamics for Regeneron Pharmaceuticals shares will prevail with possible volatility of 3.137%.
Pessimistic target level: 824.21
Optimistic target level: 850.90

REGN (REGN) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan. 850.06 803.39 889.85 9.72
Feb. 874.54 815.51 916.26 11.00
Mar. 877.69 820.82 910.87 9.89
Apr. 912.45 874.67 937.09 6.66
May. 932.98 875.04 992.60 11.84
Jun. 924.58 892.13 950.38 6.13
Jul. 917.09 880.78 969.09 9.11
Aug. 908.84 877.76 957.10 8.29
Sep. 908.02 852.45 948.88 10.16
Oct. 909.66 890.01 945.68 5.89
Nov. 942.40 881.34 982.27 10.28
Dec. 955.13 924.18 981.77 5.87

Regeneron Pharmaceuticals forecast for this year


Regeneron Pharmaceuticals Stock Prediction for Jan 2024

An uptrend is forecast for this month with an optimal target price of $850.062. Pessimistic: $803.39. Optimistic: $889.85


Regeneron Pharmaceuticals Stock Prediction for Feb 2024

An uptrend is forecast for this month with an optimal target price of $874.544. Pessimistic: $815.51. Optimistic: $916.26


Regeneron Pharmaceuticals Stock Prediction for Mar 2024

An uptrend is forecast for this month with an optimal target price of $877.692. Pessimistic: $820.82. Optimistic: $910.87


Regeneron Pharmaceuticals Stock Prediction for Apr 2024

An uptrend is forecast for this month with an optimal target price of $912.449. Pessimistic: $874.67. Optimistic: $937.09


Regeneron Pharmaceuticals Stock Prediction for May 2024

An uptrend is forecast for this month with an optimal target price of $932.979. Pessimistic: $875.04. Optimistic: $992.60


Regeneron Pharmaceuticals Stock Prediction for Jun 2024

An downtrend is forecast for this month with an optimal target price of $924.582. Pessimistic: $892.13. Optimistic: $950.38


Regeneron Pharmaceuticals Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $917.093. Pessimistic: $880.78. Optimistic: $969.09


Regeneron Pharmaceuticals Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $908.839. Pessimistic: $877.76. Optimistic: $957.10


Regeneron Pharmaceuticals Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $908.021. Pessimistic: $852.45. Optimistic: $948.88


Regeneron Pharmaceuticals Stock Prediction for Oct 2024

An uptrend is forecast for this month with an optimal target price of $909.656. Pessimistic: $890.01. Optimistic: $945.68


Regeneron Pharmaceuticals Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $942.403. Pessimistic: $881.34. Optimistic: $982.27


Regeneron Pharmaceuticals Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $955.126. Pessimistic: $924.18. Optimistic: $981.77



Regeneron Pharmaceuticals (REGN) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 991.23 946.62 1 049.22 9.78
Feb 1 021.56 956.28 1 047.30 8.69
Mar 1 082.24 1 026.72 1 132.89 9.37
Apr 1 105.62 1 050.89 1 143.43 8.09
May 1 188.21 1 166.82 1 223.50 4.63
Jun 1 206.39 1 169.47 1 230.27 4.94
Jul 1 255.25 1 196.50 1 325.29 9.72
Aug 1 300.43 1 238.40 1 377.68 10.11
Sep 1 286.39 1 245.87 1 358.17 8.27
Oct 1 299.13 1 274.57 1 363.43 6.52
Nov 1 301.46 1 249.93 1 347.15 7.22
Dec 1 276.87 1 236.64 1 329.73 7.00

Regeneron Pharmaceuticals (REGN) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 1 348.12 1 312.93 1 431.83 8.30
Feb 1 323.85 1 232.11 1 390.57 11.40
Mar 1 404.87 1 316.36 1 430.16 7.96
Apr 1 388.43 1 299.71 1 470.90 11.64
May 1 407.18 1 318.52 1 498.36 12.00
Jun 1 289.40 1 208.16 1 319.57 8.44
Jul 1 330.01 1 236.64 1 398.24 11.56
Aug 1 326.42 1 272.70 1 351.49 5.83
Sep 1 341.94 1 304.50 1 398.70 6.73
Oct 1 341.94 1 302.08 1 374.55 5.27
Nov 1 427.69 1 398.14 1 513.78 7.64
Dec 1 440.54 1 408.13 1 505.36 6.46

Regeneron Pharmaceuticals (REGN) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 1 406.83 1 334.66 1 462.54 8.74
Feb 1 475.20 1 444.66 1 577.43 8.42
Mar 1 411.47 1 326.36 1 486.42 10.77
Apr 1 361.93 1 331.29 1 415.86 5.97
May 1 383.99 1 319.22 1 432.57 7.91
Jun 1 403.92 1 330.64 1 473.42 9.69
Jul 1 436.77 1 369.53 1 492.38 8.23
Aug 1 435.48 1 352.80 1 520.75 11.04
Sep 1 506.54 1 408.91 1 608.23 12.39
Oct 1 594.67 1 535.83 1 665.00 7.76
Nov 1 695.13 1 586.82 1 783.62 11.03
Dec 1 626.48 1 582.57 1 701.14 6.97

Regeneron Pharmaceuticals (REGN) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 1 556.22 1 466.58 1 629.05 9.97
Feb 1 542.21 1 464.48 1 624.10 9.83
Mar 1 611.61 1 528.94 1 726.20 11.43
Apr 1 536.19 1 490.56 1 613.61 7.63
May 1 493.33 1 431.50 1 521.55 5.92
Jun 1 475.86 1 374.91 1 538.29 10.62
Jul 1 507.73 1 443.96 1 616.29 10.66
Aug 1 472.45 1 418.12 1 567.87 9.55
Sep 1 545.34 1 474.41 1 573.16 6.28
Oct 1 605.14 1 544.47 1 709.16 9.64
Nov 1 548.80 1 476.32 1 594.80 7.43
Dec 1 600.38 1 537.00 1 704.08 9.80

Regeneron Pharmaceuticals information and performance

Regeneron Pharmaceuticals Address

777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, US

Market Capitalization: 88 776 548 000 $

Market capitalization of the Regeneron Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of REGN shares in the company outstanding by the market price of one share.

EBITDA: 4 815 200 000 $

EBITDA of Regeneron Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: 23.26

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.755

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0078

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 35.04

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.238
Quarterly Revenue Growth YOY: 0.145
Trailing PE: 23.26

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 18.94

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 6.23

Enterprise Value (EV) /Revenue

EV To EBITDA: 16.79

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 107129000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.